Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 … Continue reading Switzerland Life Science Trend Analysis 2023
How to Use Biotechgate for Your Business Development
With over 1.4 million total entries, the comprehensive Biotechgate Business Development Database serves as a vital tool for life science professionals worldwide in their organizations. In this article, you will find just some of the reasons that Biotechgate can enhance the business development activities of you and your colleagues. Market Exploration Containing over 65,000 individual … Continue reading How to Use Biotechgate for Your Business Development
Enhancing Market Exploration: A Client’s Success Story with Biotechgate
The Challenge: The client, a leading medical technology company, faced the challenge of identifying new biotech companies across multiple regions, including Benelux, and Scandinavia, and countries such as the UK, Ireland, Germany, Austria, and France. With time constraints and limited industry visibility, the client sought an efficient way to discover potential customers in the industry … Continue reading Enhancing Market Exploration: A Client’s Success Story with Biotechgate
Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing
Tuesday, 04 July 2023 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2023 of the Dutch life sciences sector. In 2022, compared to 2021, venture financing of life science and biotech companies went down by more than 50%. Furthermore, the year-to-year growth rate of new biotech ventures has been decreasing since 2018, with … Continue reading Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing
Maryland Life Science Trend Analysis 2023
Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture … Continue reading Maryland Life Science Trend Analysis 2023
The Impact of University Spin-offs in the Life Sciences
University spin-offs have emerged as powerful drivers of innovation and commercialization in the life sciences industry. These companies, born out of academic research, have paved the way for groundbreaking technologies and advancements that have shaped the biopharma industry. In this article, we’ll explore the impact that university spin-offs are having in the life sciences. Prominent … Continue reading The Impact of University Spin-offs in the Life Sciences
Exploring Life Science Spin-offs
The foundation of companies is a dynamic process in the life science landscape. Academic spin-offs, where research is transformed into market opportunities, as well as spin-offs from other public institutions or established companies within the industry are common pathways. For business development professionals, understanding the circumstances in which companies are founded provide valuable context: It … Continue reading Exploring Life Science Spin-offs
How to Find Companies of a Certain Origin in Biotechgate
Discovering the foundation of life science companies is vital for business development professionals to stay informed about the industry’s latest trends and opportunities. Biotechgate empowers you to explore the origins of companies, identify new spin-offs and stay up-to-date on emerging start-ups. In this guide, learn how you can use Biotechgate’s advanced filters to easily search … Continue reading How to Find Companies of a Certain Origin in Biotechgate
France Life Science Trend Analysis 2023
The Healthcare Innovation 2023 strategy, launched in 2021 and supported with USD 7.9 billion, aims to establish France as a European leader in the life sciences industry by promoting innovation and growth. One year on, this plan appears to be on track: Despite uncertain market conditions and unlike most other European countries, France was able … Continue reading France Life Science Trend Analysis 2023
Canada Life Science Trend Analysis 2023
Canadian biotech private equity investment has grown steadily over the past four years, but appears to have hit its peak in 2021 – in 2022, the value of biotech equity financings failed to match the record levels of the previous year (2022: USD 599 million vs. 2021: USD 841 million). Ontario is Canada’s most active … Continue reading Canada Life Science Trend Analysis 2023